Bristol-Myers Squibb
BMY
BMY
2,474 hedge funds and large institutions have $102B invested in Bristol-Myers Squibb in 2023 Q2 according to their latest regulatory filings, with 126 funds opening new positions, 945 increasing their positions, 1,062 reducing their positions, and 163 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
11% less repeat investments, than reductions
Existing positions increased: 945 | Existing positions reduced: 1,062
23% less first-time investments, than exits
New positions opened: 126 | Existing positions closed: 163
35% less funds holding in top 10
Funds holding in top 10: 68 → 44 (-24)
Holders
2,474
Holding in Top 10
44
Calls
$1.43B
Puts
$995M
Top Buyers
| 1 | +$528M | |
| 2 | +$449M | |
| 3 | +$182M | |
| 4 |
Barclays
London,
United Kingdom
|
+$141M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$133M |
Top Sellers
| 1 | -$634M | |
| 2 | -$298M | |
| 3 | -$290M | |
| 4 |
BlackRock
New York
|
-$195M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$172M |